ADMA Biologics faces securities class action over alleged 2025 channel stuffing

The lawsuit, filed in New Jersey, follows a March 24, 2026 stock drop after a Culper Research report alleged ADMA’s reported 20% growth masked a 3% revenue decline.

Summary

verifying reliability

Terms & Concepts

No specialized terms available for this topic.